IPO Trending
INFINIUMSME / NSEListed

Infinium Pharmachem Limited

Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and GMP-compliant manufacturing facility in Gujarat spans 4,100 sq. m and is equipped to produce complex iodine derivatives. Infinium Pharmachem serves over 15 countries globally, offering more than 200 iodine derivatives and 7 APIs.

₹135 - ₹1351.84x sub
Listed Price141.50
Listing Gain+4.81%
Subscription1.84x total demandUpdated 11 Nov 2025, 12:57 PM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date31 Mar 2023
Close Date05 Apr 2023
Listing Date17 Apr 2023
Infinium Pharmachem Limited IPO Subscription | GMP, Allotment & Financials | IPO Trending